AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Nuo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026
- Market cap
- $60.99M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 48M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
2 buys · 1 sales
Net sold $290.45K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Pittman Scott M. | 5,627,500 | 11.60% | 13D (active) amendment | May 29, 2026 |
| Jacobs Paul Anthony | 3,183,500 | 6.60% | 13G (passive) amendment | Jan 23, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AURX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 4,700 | 0.01% | $4.28K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Emerson Jorden | CEO/CFO, Director | 2,070,190 | 4.27% | Aug 31, 2026 |
| Peter Clausen | CSO/COO | 773,528 | 1.60% | Jul 2, 2026 |
| Scott M. Pittman | Director, 10% owner | 5,440,000 | 11.23% | Jul 2, 2026 |
| Paul Mintz | Director | 108,294 | 0.22% | Jul 2, 2026 |
| C. Eric Winzer | Director | 212,654 | 0.44% | Jul 2, 2026 |
| Charles E. Sheedy | 10% owner | 11,574,198 | 23.90% | Aug 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David Emerson Jorden CEO/CFO, Director | Aug 28, 2026 | Buy | +7,984 | $1.09 | $8.70K | 2,070,000 |
| David Emerson Jorden CEO/CFO, Director | Aug 28, 2026 | Award | +7,984 | $1.09 | $8.70K | 2,070,000 |
| David Emerson Jorden CEO/CFO, Director | Aug 27, 2026 | Buy | +789 | $1.07 | $844 | 2,062,016 |
| David Emerson Jorden CEO/CFO, Director | Aug 27, 2026 | Award | +789 | $1.07 | $844 | 2,062,016 |
| David Emerson Jorden CEO/CFO, Director | Jun 30, 2026 | Option exercise | +162,500 | $1.00 | $162.50K | 2,222,119 |
| David Emerson Jorden CEO/CFO, Director | Jun 30, 2026 | Tax withholding | −160,892 | $1.01 | $162.50K | 2,061,227 |
| C. Eric Winzer Director | Jun 30, 2026 | Option exercise | +40,000 | $1.00 | $40.00K | 212,654 |
| C. Eric Winzer Director | Jun 30, 2026 | Tax withholding | −39,604 | $1.01 | $40.00K | 173,050 |
| Scott M. Pittman Director, 10% owner | Jun 30, 2026 | Option exercise | +40,000 | $1.00 | $40.00K | 5,440,000 |
| Scott M. Pittman Director, 10% owner | Jun 30, 2026 | Tax withholding | −39,604 | $1.01 | $40.00K | 5,400,396 |
| David Emerson Jorden CEO/CFO, Director | Jun 5, 2026 | Award | +13,245 | $1.10 | $14.57K | 2,085,000 |
| David Emerson Jorden CEO/CFO, Director | Jan 1, 2026 | Tax withholding | −25,381 | $1.97 | $50.00K | 2,046,374 |
| David Emerson Jorden CEO/CFO, Director | Jan 1, 2026 | Option exercise | +125,000 | $0.40 | $50.00K | 2,071,755 |
| C. Eric Winzer Director | Dec 17, 2025 | Option exercise | +68,750 | $0.40 | $27.50K | 186,404 |
| C. Eric Winzer Director | Dec 17, 2025 | Tax withholding | −13,750 | $2.00 | $27.50K | 172,654 |
| Paul Mintz Director | Dec 9, 2025 | Tax withholding | −9,091 | $2.20 | $20.00K | 108,294 |
| Paul Mintz Director | Dec 9, 2025 | Option exercise | +50,000 | $0.40 | $20.00K | 117,385 |
| Paul Mintz Director | Dec 9, 2025 | Option exercise | +50,000 | $0.40 | $20.00K | 117,385 |
| Paul Mintz Director | Dec 9, 2025 | Tax withholding | −9,091 | $2.20 | $20.00K | 108,294 |
| David Emerson Jorden CEO/CFO, Director | Nov 28, 2025 | Sale | −200,000 | $1.50 | $300.00K | 1,946,755 |
| Paul Mintz Director | Aug 1, 2025 | Option exercise | +87,500 | $0.40 | $35.00K | 87,500 |
| Paul Mintz Director | Aug 1, 2025 | Tax withholding | −20,115 | $1.74 | $35.00K | 67,385 |
| C. Eric Winzer Director | Aug 1, 2025 | Option exercise | +120,313 | $0.40 | $48.13K | 145,313 |
| C. Eric Winzer Director | Aug 1, 2025 | Tax withholding | −27,659 | $1.74 | $48.13K | 117,654 |
| David Emerson Jorden CEO/CFO, Director | Aug 1, 2025 | Option exercise | +92,710 | $0.40 | $37.08K | 2,168,068 |
| David Emerson Jorden CEO/CFO, Director | Aug 1, 2025 | Option exercise | +100,000 | $0.40 | $40.00K | 2,075,358 |
| David Emerson Jorden CEO/CFO, Director | Aug 1, 2025 | Tax withholding | −21,313 | $1.74 | $37.08K | 2,146,755 |
| C. Eric Winzer Director | Aug 1, 2025 | Tax withholding | −27,659 | $1.74 | $48.13K | 117,654 |
| C. Eric Winzer Director | Aug 1, 2025 | Option exercise | +120,313 | $0.40 | $48.13K | 145,313 |
| Peter Clausen CSO/COO | Jul 31, 2025 | Option exercise | +183,853 | $0.40 | $73.54K | 770,054 |
| Charles E. Sheedy 10% owner | Jul 30, 2025 | Buy | +133,333 | $1.50 | $200.00K | 11,570,833 |
| Scott M. Pittman Director, 10% owner | Jul 30, 2025 | Award | +3,946 | $1.50 | $5.92K | 5,400,000 |
| Scott M. Pittman Director, 10% owner | Nov 15, 2024 | Option exercise | +62,500 | $0.40 | $25.00K | 5,362,720 |
| Scott M. Pittman Director, 10% owner | Nov 15, 2024 | Option exercise | +33,334 | $0.50 | $16.67K | 5,396,054 |
| Scott M. Pittman Director, 10% owner | Nov 15, 2024 | Option exercise | +121,875 | $0.40 | $48.75K | 5,300,220 |
| Charles E. Sheedy 10% owner | Sep 18, 2024 | Buy | +125,000 | $0.75 | $93.75K | 11,437,500 |
| Charles E. Sheedy 10% owner | May 20, 2024 | Buy | +100,000 | $0.75 | $75.00K | 11,312,500 |
| Scott M. Pittman Director, 10% owner | May 20, 2024 | Award | +135,000 | $0.75 | $101.25K | 5,178,345 |
| Peter Clausen CSO/COO | May 20, 2024 | Award | +15,000 | $0.75 | $11.25K | 586,201 |
| Peter Clausen CSO/COO | Dec 19, 2023 | Award | +20,000 | $0.50 | $10.00K | 571,201 |
| Charles E. Sheedy 10% owner | Dec 19, 2023 | Buy | +150,000 | $0.50 | $75.00K | 11,212,500 |
| Scott M. Pittman Director, 10% owner | Dec 19, 2023 | Award | +600,000 | $0.50 | $300.00K | 5,043,345 |
| Charles E. Sheedy 10% owner | Aug 1, 2023 | Buy | +62,500 | $2.00 | $125.00K | 11,062,500 |
| Peter Clausen CSO/COO | Aug 1, 2023 | Award | +25,000 | $2.00 | $50.00K | 551,201 |
| Scott M. Pittman Director, 10% owner | Aug 1, 2023 | Award | +100,000 | $2.00 | $200.00K | 4,443,345 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −20,000 | $1.50 | $30.00K | 2,010,858 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −30,000 | $1.50 | $45.00K | 2,077,858 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −27,000 | $1.50 | $40.50K | 2,050,858 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −13,500 | $1.50 | $20.25K | 1,997,358 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −30,000 | $1.50 | $45.00K | 2,107,858 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −7,000 | $1.50 | $10.50K | 1,980,358 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −5,000 | $1.50 | $7.50K | 1,975,358 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −10,000 | $1.50 | $15.00K | 1,987,358 |
| David Emerson Jorden CEO/CFO, Director | Nov 9, 2022 | Sale | −20,000 | $1.50 | $30.00K | 2,030,858 |
| Scott M. Pittman Director, 10% owner | Apr 29, 2022 | Award | +100,000 | $1.00 | $100.00K | 4,343,345 |
| Peter Clausen CSO/COO | Apr 29, 2022 | Award | +25,000 | $1.00 | $25.00K | 526,201 |
| Charles E. Sheedy 10% owner | Apr 29, 2022 | Buy | +804,868 | $1.00 | $804.87K | 11,000,000 |
| David Emerson Jorden CEO/CFO, Director | Apr 29, 2022 | Award | +10,532 | $1.00 | $10.53K | 2,137,858 |
| Charles E. Sheedy 10% owner | Dec 30, 2021 | Option exercise | +1,431,615 | $0.20 | $286.32K | 10,195,132 |
| Scott M. Pittman Director, 10% owner | Dec 30, 2021 | Option exercise | +900,000 | $0.20 | $180.00K | 4,243,345 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.